Data Insights

By Company Name

By Disease Name

By Drug Name

By Themes

Showing 6 results out of 6

Company profileOverseas Pharmaceuticals

Access the most comprehensive report about Overseas Pharmaceuticals available on the market

Buy Now

Data Insights

OPL-026 is under clinical development by Overseas Pharmaceuticals and currently in Phase I for Epilepsy. According to GlobalData, Phase I...

Data Insights

OPL-044 is under clinical development by Overseas Pharmaceuticals and currently in Phase I for Epilepsy. According to GlobalData, Phase I...

Data Insights

OPL-053 is under clinical development by Overseas Pharmaceuticals and currently in Phase I for Insomnia. According to GlobalData, Phase I...

Data Insights

OPL-015 is under clinical development by Overseas Pharmaceuticals and currently in Phase III for Pain. According to GlobalData, Phase III...

Data Insights

OPL-022 is under clinical development by Overseas Pharmaceuticals and currently in Phase I for Hypertension. According to GlobalData, Phase I...

Data Insights

OPL-025B is under clinical development by Overseas Pharmaceuticals and currently in Phase I for Diabetes. According to GlobalData, Phase I...